TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Egetis Therapeutics AB (publ)
Closing information (x1000 EUR)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 2,031 | 3,739 | 4,051 |
Financial expenses | 63 | 18 | 89 |
Earnings before taxes | -17,415 | -10,222 | -17,845 |
EBITDA | -17,559 | -10,094 | -17,733 |
Total assets | 50,421 | 55,664 | 89,063 |
Current assets | 13,246 | 14,951 | 29,875 |
Current liabilities | 4,439 | 3,830 | 6,988 |
Equity capital | 45,488 | 51,535 | 62,727 |
- share capital | 1,015 | 850 | 866 |
Employees (average) | 15 | 11 | 9 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 90.2% | 92.6% | 70.4% |
Turnover per employee | 135 | 340 | 450 |
Profit as a percentage of turnover | -857.5% | -273.4% | -440.5% |
Return on assets (ROA) | -34.4% | -18.3% | -19.9% |
Current ratio | 298.4% | 390.4% | 427.5% |
Return on equity (ROE) | -38.3% | -19.8% | -28.4% |
Change turnover | -1,406 | -237 | -4,174 |
Change turnover % | -41% | -6% | -51% |
Chg. No. of employees | 4 | 2 | 0 |
Chg. No. of employees % | 36% | 22% | 0% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.